Of the over 400 applications for the latest edition of TSEC, the maximum (20 percent) are from the healthcare sector. This is followed by (at 18 percent) participants from the agriculture, food, dairy segment and the education vertical.
‘Kolkata-based Arogya Meditech Pvt. Ltd, has developed a product called CEREBROS, a low-cost, portable, radiation-free brain scanning device that detects brain injuries, strokes and other neurological emergencies.’
For example, Kolkata-based Arogya Meditech Pvt. Ltd, has developed a product called CEREBROS, a low-cost, portable, radiation-free brain scanning device that detects brain injuries, strokes and other neurological emergencies. It comes in the form of a wearable head-gear and combines two technologies-Near Infrared Spectroscopy and Electroencephalography.
Bengaluru-incubated biotech company OmiX Labs has designed a platform that includes a disposable biochip loaded with all reagents and a smartphone based reader for DNA analysis. Aiming to bring tests to the patients themselves, its current projects include detection of low levels of malarial parasite in blood, urinary tract infections and anti-microbial resistance.
Satya Tapas of Scidogma Research, Bengaluru, has designed an automated, POC, AI-enabled microscope that can diagnose malaria in remote areas.
TSEC is a joint initiative by the TATA group and the Indian Institute of Management Calcutta (IIM Calcutta), a national level challenge to find India's most promising social enterprises.
According to C.D. Mitra, advisor to the Centre for Entrepreneurship and Innovation at IIM Calcutta, in about five years there has been a 100 percent increase in the number of participants in the challenge.
"The maximum number of applications for the 2017 edition is from the southern part of India (35 percent). At the IIM Calcutta Innovation Park, between 30 to 40 percent applications are from social enterprises," Mitra said.
However, Ashok Banerjee of the institute said, if these social enterprises have to scale up and be among the big players they have to go for mainstream funding.